Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page
- Check5 days agoChange DetectedA new revision entry v3.5.5 was added to the study's history, indicating an updated version of the record. The prior revision v3.5.4 was removed from the visible history, affecting the sequence of past changes.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page’s revision label in the footer updated from v3.5.3 to v3.5.4, indicating a minor update to the record history.SummaryDifference0.1%

- Check40 days agoChange DetectedThe Record History shows a new revision, v3.5.3, replacing the previous v3.5.2, signaling an update to the record history. This indicates an update to the record history rather than a change to the study content.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision v3.5.2 was added to the history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check76 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3.SummaryDifference0.1%

- Check90 days agoChange DetectedNew revision entry v3.4.3 is added and v3.4.2 is removed from the study record history.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.